High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit
- PMID: 23522897
- PMCID: PMC3729120
- DOI: 10.2450/2013.0043-13
High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit
Figures
Comment on
-
Supportive treatment of severe anaemia in a Jehovah's Witness with severe trauma.Blood Transfus. 2013 Jul;11(3):452-3. doi: 10.2450/2013.0263-12. Epub 2013 Mar 19. Blood Transfus. 2013. PMID: 23522898 Free PMC article. No abstract available.
References
-
- Tobian AAR, Ness PM, Noveck H, Carson JL. Time course and etiology of death in patients with severe anemia. Transfusion. 2009;49:1395–9. - PubMed
-
- Beliaev AM, Marshall RJ, Gordon M, et al. Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang. 2012;103:18–24. - PubMed
-
- Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42:812–8. - PubMed
-
- Beliaev AM, Marshall RJ, Smith W, Windsor JA. Treatment monitoring and mortality risk adjustment in anaemic Jehovah’s Witnesses. ANZ J Surg. 2013;83:161–4. - PubMed
-
- Beliaev AM, Marshall RJ, Smith W, Windsor JA. Mortality Risk Stratification in Severely Anaemic Jehovah’s Witness Patients. Intern Med J. 2012;42:e1–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical